Latent Tuberculosis: all 199 studies
Page 2 of 2. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.
- Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)Status unknownNCT04988984
- COPD Co-infection With Tuberculosis on Th17 Cell DifferentiationCompletedNCT04966052
- Impact of LTBI Treatment on Glucose Tolerance and Chronic InflammationCompletedNCT04830462Phase 4
- Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African CountriesActive, not recruitingNCT04781257
- European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric ProtocolStatus unknownNCT04677842
- Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS TuberculosisStatus unknownNCT04620772Phase 2/3
- TB Screening Improves Preventive Therapy UptakeActive, not recruitingNCT04557176Not applicable
- Microneedles for Diagnosis of LTBITerminatedNCT04552015Not applicable
- Computer Aided Screening for Tuberculosis in Low Resource EnvironmentsCompletedNCT04545164Not applicable
- GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact AssessmentCompletedNCT04528823Not applicable
- Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB TrialCompletedNCT04494516
- MDR-TB Close Contacts Tracing in China (TCCT Study)Status unknownNCT04484129
- Immunization With BCG Vaccine to Prevent Tuberculosis InfectionTerminatedNCT04453293Phase 3
- The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ETStatus unknownNCT04443283
- To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 PandemicStatus unknownNCT04412239Not applicable
- Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, IndiaCompletedNCT04342598
- Implementation of an Integrated Care Strategy for Children Contacts of Patients With TuberculosisCompletedNCT04331262
- Tuberculosis In Children Visiting Friends and RelativesStatus unknownNCT04236765Not applicable
- Evaluation of Immune Cell Markers in Diagnosis of TuberculosisStatus unknownNCT04148053
- Screening for Tuberculosis in PregnancyCompletedNCT04098341Not applicable
- Risk of SDRs Under 3HP and 1HP Regimen for LTBICompletedNCT04094012Phase 3
- Performance Evaluation of the VIDAS TB-IGRA Assay.CompletedNCT04048018
- 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.CompletedNCT03988933Phase 2
- Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected PatientsStatus unknownNCT03941210
- Prevalence of Latent Tuberculosis in High Risk ChildrenStatus unknownNCT03910946
- Video Based Directly Observed Therapy for Latent TBWithdrawnNCT03783728
- Evaluation of Diabetes Control and Effect on Transmission and Development of TuberculosisWithdrawnNCT03498534Phase 4
- Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected MothersCompletedNCT03383211
- Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis InfectionStatus unknownNCT03312647
- Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)CompletedNCT03278483Phase 4
- Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized PatientsCompletedNCT03271567
- A Phase II Study of H56:IC31 in Healthy AdolescentsWithdrawnNCT03265977Phase 2
- Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and AdolescentsCompletedNCT03230409Not applicable
- Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CTStatus unknownNCT03220464Not applicable
- Xpert Ultra and Xpert HIV-VL in People Living With HIVCompletedNCT03187964Not applicable
- Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent TuberculosisCompletedNCT03069807Not applicable
- Latent Tuberculosis Infection in Korean Health Care WorkersStatus unknownNCT03010111Not applicable
- Serological Test for the Diagnosis of TBTerminatedNCT02898623
- Efficacy of Nyaditum Resae(R) Against Active TB in GeorgiaStatus unknownNCT02897180Phase 2/3
- Trial of Vitamin D Supplementation in Cape Town Primary SchoolchildrenCompletedNCT02880982Phase 3
- Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and TreatmentCompletedNCT02810678Not applicable
- Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis PopulationStatus unknownNCT02782494
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersCompletedNCT02771249Phase 1
- Testing for Tuberculosis in the United Kingdom HIV Infected PopulationStatus unknownNCT02712671
- Promoting Adherence to Treatment for Latent TB Infection Through Text MessagingCompletedNCT02690818Not applicable
- VDOT for Monitoring Adherence to LTBI TreatmentCompletedNCT02641106Not applicable
- New Generation IGRA in Immunocompromised IndividualsCompletedNCT02639936
- Improving the Detection of Active Tuberculosis in Accident and Emergency DepartmentsStatus unknownNCT02512484
- Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis ContactsCompletedNCT02454738Not applicable
- Vitamin D Supplementation in TB PreventionCompletedNCT02276755Phase 3
- Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth InfectionTerminatedNCT02225158
- Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in TaiwanStatus unknownNCT02208427Phase 3
- Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network AnalysisCompletedNCT02175849
- Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South AfricaCompletedNCT02119130Not applicable
- Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli AdultsCompletedNCT02073669Not applicable
- The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot StudyCompletedNCT02042261
- Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)Status unknownNCT01875952Phase 4
- The Epidemiology of TST Change in KoreaCompletedNCT01850043
- Equivalence Study of Specificity of PPDStatus unknownNCT01798095Phase 2
- "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".TerminatedNCT01761201Phase 3
- Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)Status unknownNCT01689831Phase 2
- The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis InfectionStatus unknownNCT01685905
- Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term DialysisStatus unknownNCT01685086
- The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary TuberculosisStatus unknownNCT01676155
- Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to TuberculosisCompletedNCT01622140
- Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant RecipientsCompletedNCT01608685
- Determining Risk in Latent TuberculosisTerminatedNCT01571739
- TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI TreatmentStatus unknownNCT01549457Early Phase 1
- Effect of Filarial Infection on Immune Responses in Latent TuberculosisCompletedNCT01547884
- Evaluating Diagnostics for Paediatric Tuberculosis by Blood CultureCompletedNCT01434758
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)Status unknownNCT01398618Phase 3
- Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term DialysisCompletedNCT01311999
- Treatment of Mycobacterium Xenopi Pulmonary InfectionCompletedNCT01298336Phase 3
- Characterization and Evaluation of Diagnostic Biomarkers for TuberculosisCompletedNCT01269268
- QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.CompletedNCT01223534Phase 4
- Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis InfectionCompletedNCT01162265
- Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis InfectionCompletedNCT01136161Phase 2
- Improving Latent Tuberculosis (TB) Diagnosis in Thai ChildrenCompletedNCT00947609
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectivenessCompletedNCT00931736Phase 3
- Demonstration of the Dynamic Hypothesis of Latent Tuberculosis InfectionStatus unknownNCT00905970
- Study of Latent Tuberculosis Infection (LTBI) by High Resolution ScannerStatus unknownNCT00904956
- Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected PatientsCompletedNCT00805272Not applicable
- Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?CompletedNCT00763295
- T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised IndividualsCompletedNCT00707317
- Detection of Latent Tuberculosis in Hemodialysis PatientsCompletedNCT00695734
- Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infectionStatus unknownNCT00692809
- Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent TuberculosisWithdrawnNCT00558480Not applicable
- Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration AreaCompletedNCT00557765
- Diagnosis of Tuberculosis Infection in HIV Co-infected ChildrenCompletedNCT00541294
- Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected PersonsCompletedNCT00463086Not applicable
- Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness AnalysisStatus unknownNCT00449345
- Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver DiseaseCompletedNCT00402402Phase 4
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis InfectionTerminatedNCT00397709Phase 4
- Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care WorkersStatus unknownNCT00311220Phase 4
- Treatment of Latent Tuberculosis Infection With IsoniazidCompletedNCT00293228Phase 4
- Immune Response to Mycobacterium Tuberculosis InfectionCompletedNCT00257907
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)CompletedNCT00170209Phase 3
- Effects of Vitamin D Supplementation on Antimycobacterial ImmunityCompletedNCT00157066Not applicable
- Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised PopulationsCompletedNCT00134342